Contemporary Concepts in Toxicology (CCT) Meetings

Upcoming CCT Events

There are no scheduled Contemporary Concepts in Toxicology (CCT) meetings. Effective June 2022, only proposals for CCT webinars should be submitted and will be considered by the Collaborative Conferences Committee. The information on this web page will be updated when submissions for face-to-face CCT meeting proposals begin again.

About CCT Meetings

Currently on hiatus, Contemporary Concepts in Toxicology (CCT) meetings are one- to two-day focused, open registration, scientific meetings in contemporary and rapidly progressing areas of toxicological sciences. CCT meetings may be held as satellites to the SOT Annual Meeting and ToxExpo, Specialty Section, or Regional Chapter meetings or may be held independently. Meetings also may be held virtually. The intent of the CCT meetings is to provide a forum for dissemination and discussion of those developments that are likely to have the greatest importance for advancing the science of toxicology. In order to maintain the quality standards of the Society, only meetings in which SOT maintains scientific and administrative control will be considered as CCT meetings.

While face-to-face meetings are on hiatus, proposals for CCT webinars will be entertained by the Collaborative Conferences Committee. Consult the “How to Propose and Plan a CCT Event” web page and review this sample proposal for more information on how to submit a CCT webinar for consideration.

Previous CCT Events

Recordings of select past CCT Webinars are available on the SOT Webinars page.

  • FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals—May 10–11, 2022, University of North Carolina at Chapel Hill Friday Center Chapel Hill, North Carolina
  • FutureTox IV Progress to Maturity: Predictive Toxicology for Healthy Children—November 14–16, 2018, Arlington (Crystal City), VA
  • Building a Better Epithelium March 10, 2018, San Antonio, Texas
  • Toxicological Concerns in Older Adults, A Neglected Majority—March 10, 2018, San Antonio, Texas
  • Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic—March 11, 2017, Baltimore, Maryland
  • Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment—November 2–4, 2016, Tysons, Virginia
  • The Use of Cardiomyocytes for the Assessment of Proarrhythmic Risk—October 25–26, 2016, Arlington, Virginia
  • Ocular Toxicology, Pharmacology and Drug Delivery: An Eye on the Future—June 27 & 28, 2016, South San Francisco, California
  • MiRNA Biomarkers for Toxicology—March 12, 2016, New Orleans, Louisiana
  • FutureTox III: Transforming 21st Century Science into Risk Assessment and Regulatory Decision-Making—November 19–20, 2015, Arlington, Virginia
  • Risk Assessment of Humanized Monoclonal Antibodies and Antibody—Drug Conjugates; and Risk Assessment of Oligonucleotide Constructs—April 16, 2015, Webinar
  • Regulatory Toxicology Testing for Small Molecules: Strategies and Outcome Analysis; and Risk Assessment of “Traditional” Biologics—February 25, 2015, Webinar
  • FutureTox II: In Vitro Data and In Silico Models for Predictive Toxicology—January 16–17, 2014, Chapel Hill, North Carolina
  • FutureTox: Building the Road for 21st Century Toxicology and Risk Assessment Practices—October 18–19, 2012, Arlington, Virginia
  • PPTOX III: Environmental Stressors in the Developmental Origins of Disease: Evidence and Mechanisms—May 14–16, 2012, Paris, France
  • Building for Better Decisions: Multi-Scale Integration of Human Health and Environmental Data—May 8–11, 2012, US EPA, Research Triangle Park, North Carolina
  • PPTOXII: Role of Environmental Stressors in the Developmental Origins of Disease—December 7–10, 2009, Arlington, Virginia
  • Hemangiosarcoma in Rodents: Mode-of-Action Evaluation and Human Relevance Workshop—December 4–5, 2008, Arlington, Virginia
  • Perfluorinalkyl Acids and Related Chemistries: Toxicokinetics and Mode-of-Action Workshop—February 14–16, 2007, Arlington, Virginia
  • Probabilistic Risk Assessment (PRA): Bridging Components Along the Exposure-Dose-Response Continuum—July 25–27, 2005, Washington, DC
  • Charting the Future: Building the Scientific Foundation for Mixtures Joint Toxicity and Risk Assessment—February 16–17, 2005, Atlanta, Georgia
  • Joint Specialty Symposium on Renal Toxicology and Toxicology Pathology: An Integration of Mechanistic Investigation and Morphological Evaluation—September 27–October 1, 2004, Lindau/Bodensee, Germany
  • Vaccines: Non-Clinical Safety Evaluation of Preventive Vaccines: Recent Advances and Regulatory Considerations 2002—December 2–4, 2002, Arlington, Virginia
  • Use of Genomic Data in Risk Assessment: State-of-the-Art 2001—November 7–8, 2001, Washington, DC
  • In Vitro Human Tissue Models in Risk Assessment—September 20–22, 2001
  • Mechanisms of Nephrotoxicity and Nephrocarcinogenicity—April 15–18, 2000, Martha's Vineyard, Maine
  • Harmonization of Cancer and Non-Cancer Risk Assessment—November 1–3, 1999, Arlington, Virginia